|
1
|
Kamisawa T, Wood LD, Itoi T and Takaori K:
Pancreatic cancer. Lancet. 388:73–85. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen W, Sun K, Zheng R, Zeng H, Zhang S,
Xia C, Yang Z, Li H, Zou X and He J: Cancer incidence and mortality
in China, 2014. Chin J Cancer Res. 30:1–12. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ashktorab H, Kupfer SS, Brim H and
Carethers JM: Racial disparity in gastrointestinal cancer risk.
Gastroenterology. 153:910–923. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chun YS, Pawlik TM and Vauthey JN: 8th
Edition of the AJCC cancer staging manual: Pancreas and
hepatobiliary cancers. Ann Surg Oncol. 25:845–847. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Rombouts SJ, Vogel JA, van Santvoort HC,
van Lienden KP, van Hillegersberg R, Busch OR, Besselink MG and
Molenaar IQ: Systematic review of innovative ablative therapies for
the treatment of locally advanced pancreatic cancer. Br J Surg.
102:182–193. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
8
|
Martin RC II, Kwon D, Chalikonda S,
Sellers M, Kotz E, Scoggins C, McMasters KM and Watkins K:
Treatment of 200 locally advanced (stage III) pancreatic
adenocarcinoma patients with irreversible electroporation: Safety
and efficacy. Ann Surg. 262:486–494; discussion 492–494. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cantore M, Girelli R, Mambrini A, Frigerio
I, Boz G, Salvia R, Giardino A, Orlandi M, Auriemma A and Bassi C:
Combined modality treatment for patients with locally advanced
pancreatic adenocarcinoma. Br J Surg. 99:1083–1088. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhou Y: High-intensity focused ultrasound
treatment for advanced pancreatic cancer. Gastroenterol Res Pract.
2014:1–11. 2014. View Article : Google Scholar
|
|
11
|
Wu F: High intensity focused ultrasound: A
noninvasive therapy for locally advanced pancreatic cancer. World J
Gastroenterol. 20:16480–16488. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wu F, Wang ZB, Chen WZ, Wang W, Gui Y,
Zhang M, Zheng G, Zhou Y, Xu G, Li M, et al: Extracorporeal high
intensity focused ultrasound ablation in the treatment of 1,038
patients with solid carcinomas in China: An overview. Ultrason
Sonochem. 11:149–154. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Marinova M, Strunk HM, Rauch M, Henseler
J, Clarens T, Brüx L, Dolscheid-Pommerich R, Conrad R, Cuhls H,
Radbruch L, et al: High-intensity focused ultrasound (HIFU) for
tumor pain relief in inoperable pancreatic cancer: Evaluation with
the pain sensation scale (SES). Schmerz. 31:31–39. 2016.(In
German). View Article : Google Scholar
|
|
14
|
Marinova M, Huxold HC, Henseler J, Mücke
M, Conrad R, Rolke R, Ahmadzadehfar H, Rauch M, Fimmers R,
Luechters G, et al: Clinical effectiveness and potential survival
benefit of US-guided high-intensity focused ultrasound therapy in
patients with advanced-stage pancreatic cancer. Ultraschall Med.
40:625–637. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang K, Zhu H, Meng Z, Chen Z, Lin J, Shen
Y and Gao H: Safety evaluation of high-intensity focused ultrasound
in patients with pancreatic cancer. Onkologie. 36:88–92. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Strunk H, Lützow, Henseler J, Mücke M,
Rauch M, Marx C, Schild HH and Marinova M: Mesenteric vessel
patency following HIFU therapy in patients with locally invasive
pancreatic cancer. Ultraschall Med. 39:650–658. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiong LL, Hwang JH, Huang XB, Yao SS, He
CJ, Ge XH, Ge HY and Wang XF: Early clinical experience using high
intensity focused ultrasound for palliation of inoperable
pancreatic cancer. JOP. 10:123–129. 2009.PubMed/NCBI
|
|
18
|
Sofuni A, Moriyasu F, Sano T, Itokawa F,
Tsuchiya T, Kurihara T, Ishii K, Tsuji S, Ikeuchi N, Tanaka R, et
al: Safety trial of high-intensity focused ultrasound therapy for
pancreatic cancer. World J Gastroenterol. 20:9570–9577. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Anzidei M, Marincola BC, Bezzi M,
Brachetti G, Nudo F, Cortesi E, Berloco P, Catalano C and Napoli A:
Magnetic resonance-guided high-intensity focused ultrasound
treatment of locally advanced pancreatic adenocarcinoma:
Preliminary experience for pain palliation and local tumor control.
Invest Radiol. 49:759–65. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shi Y, Ying X, Hu X, Zhao J, Fang X, Wu M,
Chen TZ and Shen H: Influence of high intensity focused ultrasound
(HIFU) treatment to the pancreatic function in pancreatic cancer
patients. Pak J Pharm Sci. 28 (Suppl 3):S1097–S1100. 2015.
|
|
21
|
Strunk HM, Henseler J, Rauch M, Mücke M,
Kukuk G, Cuhls H, Radbruch L, Zhang L, Schild HH and Marinova M:
Clinical use of high-intensity focused ultrasound (HIFU) for tumor
and pain reduction in advanced pancreatic cancer. Rofo.
188:662–670. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi Y, Ying X, Hu X and Shen H: Pain
management of pancreatic cancer patients with high-intensity
focused ultrasound therapy. Pak J Pharm Sci. 30 (Suppl
1):S303–S307. 2017.
|
|
23
|
Dababou S, Marrocchio C, Rosenberg J,
Bitton R, Pauly KB, Napoli A, Hwang JH and Ghanouni P: A
meta-analysis of palliative treatment of pancreatic cancer with
high intensity focused ultrasound. J Ther Ultrasound. 5:92017.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wei W, Jie T and Huiyi Y: Ablation effects
of high-intensity focused ultrasound therapy on pancreatic cancer.
Chin J Ultrasound Med. 76–79. 2007.
|
|
25
|
Orsi F, Zhang L, Arnone P, Orgera G,
Bonomo G, Vigna PD, Monfardini L, Zhou K, Chen W, Wang Z and
Veronesi U: High-intensity focused ultrasound ablation: Effective
and safe therapy for solid tumors in difficult locations. AJR Am J
Roentgenol. 195:W245–W252. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Christensen E, Schlichting P, Fauerholdt
L, Gluud C, Andersen PK, Juhl E, Poulsen H and Tygstrup N:
Prognostic value of Child-Turcotte criteria in medically treated
cirrhosis. Hepatology. 4:430–435. 2010. View Article : Google Scholar
|
|
27
|
Jia L, Binsheng F, Rongqin Z, et al: Value
of ultrasonography in preoperative evaluation of vascular invasion
and resectability of pancreatic cancer. Chin J Hepatic Surg.
410–413. 2018.
|
|
28
|
Kun Z, Dimitrov DD, Andreev TV, Liang W,
Feradova H, Gorchev AG, Hui Z and Zhibiao W: One-year survival of
inoperable pancreatic cancer treated by high intensity focused
ultrasound: A retrospective multiple-center clinical trial in China
and Bulgaria. J Chongqing Med Univ. 40:378–382. 2015.
|
|
29
|
Wu F, Wang ZB, Zhu H, Chen WZ, Zou JZ, Bai
J, Li KQ, Jin CB, Xie FL and Su HB: Feasibility of US-guided
high-intensity focused ultrasound treatment in patients with
advanced pancreatic cancer: Initial experience. Radiology.
236:1034–1040. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bin HU, Wei LV and Dan W: Effect of HIFU
on relieving the pain of advanced pancreatic cancer. J
Hepatopancreatobiliary Surg. 105–108. 2014.
|
|
31
|
Sung HY, Jung SE, Cho SH, Zhou K, Han JY,
Han ST, Kim JI, Kim JK, Choi JY, Yoon SK, et al: Long-term outcome
of high-intensity focused ultrasound in advanced pancreatic cancer.
Pancreas. 40:1080–1086. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Vidal-Jove J, Perich E, Jaen A and
Castillo Manuel AD: Ultrasound guided high intensity focused
ultrasound (USgHIFU) for malignant tumors: Survival advantage in
stage III and IV pancreatic cancer. J Ther Ultrasound. 3 (Suppl
1):O792015. View Article : Google Scholar
|
|
33
|
Zhao J, Zhao F, Shi Y, Deng Y, Hu X and
Shen H: The efficacy of a new high intensity focused ultrasound
therapy for locally advanced pancreatic cancer. J Cancer Res Clin
Oncol. 143:2105–2111. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Ji Y, Zhang Y, Zhu J, Zhu L, Zhu Y, Hu K
and Zhao H: Response of patients with locally advanced pancreatic
adenocarcinoma to high-intensity focused ultrasound treatment: A
single-center, prospective, case series in China. Cancer Manag Res.
10:4439–4446. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhang L, Zhu H, Jin C, Zhou K, Li K, Su H,
Chen W, Bai J and Wang Z: High-intensity focused ultrasound (HIFU):
Effective and safe therapy for hepatocellular carcinoma adjacent to
major hepatic veins. Eur Radiol. 19:437–445. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Jiang F, He M, Liu Y, Huang X, Zhang L,
Bai J and Wang Z: Pathological observation after MRI guided high
intensity focused ultrasound therapy for ablating the liver tissues
adjacent to goat portal vein. Sheng Wu Yi Xue Gong Cheng Xue Za
Zhi. 28:666–669. 2011.(In Chinese). PubMed/NCBI
|
|
37
|
Mingdong J, Jin B and Zhibiao W:
Hemodynamic changes of the atheromatous abdominal aorta of rabbits
treated with high intensity focused ultrasound. J Clin Ultrasound
Med. 196–198. 2004.
|
|
38
|
Marik PE, Monnet X and Teboul JL:
Hemodynamic parameters to guide fluid therapy. Ann Intensive Care.
1:12011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jung SE, Cho SH, Jang JH and Han JY:
High-intensity focused ultrasound ablation in hepatic and
pancreatic cancer: Complications. Abdom Imaging. 36:185–195. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gao HF, Wang K, Meng ZQ, Chen Z, Lin JH,
Zhou ZH, Wang P, Shi WD and Sheng YH: High intensity focused
ultrasound treatment for patients with local advanced pancreatic
cancer. Hepatogastroenterology. 60:1906–1910. 2013.PubMed/NCBI
|
|
41
|
Wang G and Zhou D: Preoperative ultrasound
ablation for borderline resectable pancreatic cancer: A report of
30 cases. Ultrason Sonochem. 27:694–702. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Girelli R, Frigerio I, Salvia R, Barbi E,
Tinazzi Martini P and Bassi C: Feasibility and safety of
radiofrequency ablation for locally advanced pancreatic cancer. Br
J Surg. 97:220–225. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Girelli R, Frigerio I, Giardino A, Regi P,
Gobbo S, Malleo G, Salvia R and Bassi C: Results of 100 pancreatic
radiofrequency ablations in the context of a multimodal strategy
for stage III ductal adenocarcinoma. Langenbecks Arch Surg.
398:63–69. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Mansson C, Brahmstaedt R, Nilsson A,
Nygren P and Karlson BM: Percutaneous irreversible electroporation
for treatment of locally advanced pancreatic cancer following
chemotherapy or radiochemotherapy. Eur J Surg Oncol. 42:1401–1406.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Yan L, Chen YL, Su M, Liu T, Xu K, Liang
F, Gu WQ and Lu SC: A single-institution experience with open
irreversible electroporation for locally advanced pancreatic
carcinoma. Chin Med J (Engl). 129:2920–2925. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Scheffer HJ, Vroomen LG, de Jong MC,
Melenhorst MC, Zonderhuis BM, Daams F, Vogel JA, Besselink MG, van
Kuijk C, Witvliet J, et al: Ablation of locally advanced pancreatic
cancer with percutaneous irreversible electroporation: Results of
the phase I/II PANFIRE study. Radiology. 282:585–597. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Kluger MD, Epelboym I, Schrope BA,
Mahendraraj K, Hecht EM, Susman J, Weintraub JL and Chabot JA:
Single-institution experience with irreversible electroporation for
T4 pancreatic cancer: First 50 patients. Ann Surg Oncol.
23:1736–1743. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Narayanan G, Hosein PJ, Beulaygue IC,
Froud T, Scheffer HJ, Venkat SR, Echenique AM, Hevert EC,
Livingstone AS, Rocha-Lima CM, et al: Percutaneous image-guided
irreversible electroporation for the treatment of unresectable,
locally advanced pancreatic adenocarcinoma. J Vasc Interv Radiol.
28:342–348. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Frigerio I, Girelli R, Giardino A, Regi P,
Salvia R and Bassi C: Short term chemotherapy followed by
radiofrequency ablation in stage III pancreatic cancer: Results
from a single center. J Hepatobiliary Pancreat Sci. 20:574–577.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
D'Onofrio M, Crosara S, De Robertis R,
Butturini G, Salvia R, Paiella S, Bassi C and Mucelli RP:
Percutaneous radiofrequency ablation of unresectable locally
advanced pancreatic cancer: Preliminary results. Technol Cancer Res
Treat. 16:285–294. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Zhang Y, Shi J, Zeng J, Alnagger M, Zhou
L, Fang G, Long X, Pan Z, Li Y, Chen J, et al: Percutaneous
irreversible electroporation for ablation of locally advanced
pancreatic cancer: Experience From a Chinese institution. Pancreas.
46:e12–e14. 2017. View Article : Google Scholar : PubMed/NCBI
|
